The Promises of CRISPR Genome Editing in Biomedicine
Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the…
Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the…
The digital transformation of biopharmaceutical process development is known as Bioprocessing 4.0. Using the internet…
Cardiovascular diseases may not regularly grab the headlines, but they’re the leading cause of mortality…
The biologics market is increasingly important and continues to grow. Hence, biopharmaceutical companies must adapt…
A recent patent fight between the liquid biopsy companies Natera and Inivata is only the…
In just a few years, exosomes have started gaining recognition as a solution to deliver…
Natural killer cells are becoming a hot topic in the booming cancer cell therapy scene,…
Robotics and artificial intelligence are rapidly changing the way we discover drugs. Martin-Immanuel Bittner, CEO…
This month’s €6B acquisition of the UK heavyweight GW Pharmaceuticals by Jazz Pharmaceuticals has been…
As we prepare for long-distance space travel and life on Mars, biotechnology will be essential…
The prevalence of neurological diseases has increased rapidly, and they are now the second biggest…
The major research funder CRUK and two of the biotech companies it works with have…